These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 7714976

  • 21. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 22. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ, Presti JC, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL, SEARCH Database Study Group.
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Jun; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 26. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR.
    J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
    [Abstract] [Full Text] [Related]

  • 27. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
    Taneja SS, Penson DF, Epelbaum A, Handler T, Lepor H.
    J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
    [Abstract] [Full Text] [Related]

  • 28. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C, Louis P, Civantos F, Soloway MS.
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [Abstract] [Full Text] [Related]

  • 29. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
    Cheng L, Koch MO, Juliar BE, Daggy JK, Foster RS, Bihrle R, Gardner TA.
    J Clin Oncol; 2005 May 01; 23(13):2911-7. PubMed ID: 15860849
    [Abstract] [Full Text] [Related]

  • 30. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA, Lee HJ, Kim KG, Kim SH, Lee SE, Choe GY.
    Int J Urol; 2007 Aug 01; 14(8):704-8. PubMed ID: 17681059
    [Abstract] [Full Text] [Related]

  • 31. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H.
    BJU Int; 2008 Jan 01; 101(2):170-4. PubMed ID: 18173824
    [Abstract] [Full Text] [Related]

  • 32. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI.
    J Urol; 2011 Sep 01; 186(3):790-7. PubMed ID: 21788055
    [Abstract] [Full Text] [Related]

  • 33. Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer.
    Furuya Y, Fuse H, Nagakawa O, Masai M.
    Int J Clin Oncol; 2002 Apr 01; 7(2):109-13. PubMed ID: 12018107
    [Abstract] [Full Text] [Related]

  • 34. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS, Leibovich BC, Weaver AL, Lieber MM.
    J Urol; 2001 Jul 01; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [Abstract] [Full Text] [Related]

  • 35. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A, Tareen B, Lepor H.
    Prostate Cancer Prostatic Dis; 2009 Jul 01; 12(2):204-8. PubMed ID: 19238170
    [Abstract] [Full Text] [Related]

  • 36. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S, Trock BJ, Netto GJ, Epstein JI.
    Am J Surg Pathol; 2011 Sep 01; 35(9):1351-5. PubMed ID: 21836493
    [Abstract] [Full Text] [Related]

  • 37. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE.
    Cancer; 2007 Jun 15; 109(12):2432-8. PubMed ID: 17497649
    [Abstract] [Full Text] [Related]

  • 38. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K.
    Int J Urol; 2007 Aug 15; 14(8):713-8. PubMed ID: 17681061
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of extended pattern technique for initial prostate biopsy.
    Siu W, Dunn RL, Shah RB, Wei JT.
    J Urol; 2005 Aug 15; 174(2):505-9. PubMed ID: 16006881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.